The ROE as of October 2024 (TTM) for Medicenna Therapeutics Corp. (MDNA) is -49.80%

According to Medicenna Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is -49.80%. This represents a change of 287.85% compared to the average of -12.84% of the last 4 quarters.

Medicenna Therapeutics Corp. (MDNA) Historical ROE (quarterly & annually)

How has MDNA ROE performed in the past?

The mean historical ROE of Medicenna Therapeutics Corp. over the last ten years is 372.47%. The current -49.80% ROE has changed -113.37% with respect to the historical average. Over the past ten years (40 quarters), MDNA's ROE was at its highest in in the December 2015 quarter at 0%. The ROE was at its lowest in in the September 2019 quarter at -983.91%.

Medicenna Therapeutics Corp. (MDNA) ROE by Quarter and Year

Discovering the peaks and valleys of Medicenna Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Medicenna Therapeutics Corp. (MDNA) Average ROE

How has MDNA ROE performed in the past?

The current ROE of Medicenna Therapeutics Corp. (MDNA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Medicenna Therapeutics Corp. (MDNA) ROE vs. Peers

How is MDNA’s ROE compared to its peers?

Medicenna Therapeutics Corp.’s ROE is greater than Achilles Therapeutics plc (-47.36%), less than Checkpoint Therapeutics, Inc. (292.43%), greater than Cue Biopharma, Inc. (-142.93%), greater than Pieris Pharmaceuticals, Inc. (-97.28%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Ikena Oncology, Inc. (-42.81%), greater than Ovid Therapeutics Inc. (-33.40%), less than Connect Biopharma Holdings Limited (7.21%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Protara Therapeutics, Inc. (-55.03%), less than Vaccinex, Inc. (1.11%), greater than Monopar Therapeutics Inc. (-110.60%), greater than Miromatrix Medical Inc. (-119.21%), greater than Surrozen, Inc. (-178.66%), greater than Passage Bio, Inc. (-70.73%), greater than Magenta Therapeutics, Inc. (-61.71%), greater than TRACON Pharmaceuticals, Inc. (-237.65%), greater than Invivyd, Inc. (-109.72%), greater than Aptevo Therapeutics Inc. (-266.14%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Oncorus, Inc. (-130.61%), greater than SAB Biotherapeutics, Inc. (-94.04%), less than Akari Therapeutics, Plc (1.04%),

Build a custom stock screener for Medicenna Therapeutics Corp. (MDNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medicenna Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medicenna Therapeutics Corp. (MDNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medicenna Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.